Do patients who ‘feel better’ necessarily ‘do better’? Recognising the role of cognitive impairment in the assessment and management of depression.
There has been a shift from the treatment goal of symptom reduction to achieving functional remission. Cognition is central to the positive mental health and functioning treasured by patients, and it is an aspect of depression that we have neglected.
Related content
One hypothesis of the cycle of anhedonia (loss of interest or pleasure) in patients with depression is illustrated in this image; this hypothesis comes from a series of experiments performed on a sample of psychology students.
As adjunctive treatment in MDD, some dopamine–serotonin receptor antagonists are associated with sedating side effects, while others are more often associated with ‘activating’ side effects.